HMGN5 blockade by siRNA enhances apoptosis, suppresses invasion and increases chemosensitivity to temozolomide in meningiomas

International Journal of Oncology
Jing HeDewei Gao

Abstract

The high-mobility group nucleosome-binding protein-5 (HMGN5) is frequently overexpressed in various malignant cancers. However, the potential correlation between HMGN5 and prognosis in patients with meningiomas remains unknown. In the present study, we explored the expression of HMGN5 in meningiomas with immunohistochemistry and correlated the results to the patient outcome. Potential effects of HMGN5 on tumor growth, apoptosis and invasion were also examined in representative cell lines (IOMM-Lee and CH157) by downregulating HMGN5 with RNA interference (siRNA). We demonstrate that there is a positive association between HMGN5 expression and meningioma histological grade. Statistical analysis reveals that lower HMGN5 expression predict lower meningioma recurrence. In addition, downregulation of HMGN5 inhibits IOMM-Lee and CH157 cell proliferation, enhances cell apoptosis and suppresses tumor invasion. Our results further revealed that HMGN5 inhibition decreased P-glycoprotein (MDR-1) expression without affecting multidrug resistance associated proteins 1 (MRP-1) expression to increase chemosensitivity to temozolomide (TMZ) of meningioma cells. Collectively, this study indicates that HMGN5 is a novel target for developing effect...Continue Reading

References

Apr 14, 2004·Neurology·Marc C ChamberlainSusan Groshen
Sep 17, 2005·Journal of Bioenergetics and Biomembranes·Lucian Soane, Gary Fiskum
Dec 22, 2005·Frontiers in Bioscience : a Journal and Virtual Library·Aruna BasuSubrata Haldar
Aug 9, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M SchaichD Krex
Feb 4, 2010·Biochimica Et Biophysica Acta·Mark RochmanMichael Bustin
Mar 5, 2011·Journal of Neuro-oncology·Jintao QuYicheng Lu
Jun 23, 2011·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Wasilijiang WahafuLi-Qun Zhou
Jul 19, 2011·Developmental Cell·Jean-Claude Martinou, Richard J Youle
Oct 27, 2011·The Oncologist·Santosh SarafJ Lee Villano
Mar 7, 2013·Current Neurology and Neuroscience Reports·Ali-Reza Fathi, Ulrich Roelcke
Sep 14, 2013·Frontiers in Oncology·Brian P WalcottJay S Loeffler
Nov 13, 2013·Current Opinion in Structural Biology·Jeremy Murray, Adam R Renslo
Jan 18, 2014·Seminars in Interventional Radiology·Gregory J DubelGregory M Soares
Oct 4, 2014·Journal of Cell Death·Jenna M McCracken, Lee-Ann H Allen
Feb 11, 2015·Experimental and Therapeutic Medicine·Genhua LiFeng Jin

❮ Previous
Next ❯

Citations

Apr 13, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Monika ŚwierczewskaRadosław Januchowski
Nov 24, 2017·Frontiers in Cellular and Infection Microbiology·Li-Li LiuTian-Ci Yang
Sep 16, 2017·Journal of Biochemical and Molecular Toxicology·Xiaoping LiuSuge Wu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.